Objective: To assess tumor markers in oropharynx cancer.
Design: Marker expression and clinical outcome.
Patients: Forty-two patients with advanced oropharyngeal cancer treated with chemoradiation therapy.
Intervention: Treatment with chemoradiation therapy.
Main Outcome Measures: Expression of p53 and Bcl-xL in tumor tissues was assessed for correlation with chemotherapy response and survival.
Kumar B, Lee JS, Cordell KG, et al. P186 p53 and Bcl-xL Expression Predicts Outcome in Patients With Oropharynx Cancer Treated With Chemoradiation. Arch Otolaryngol Head Neck Surg. 2006;132(8):901. doi:10.1001/archotol.132.8.901-a
Artificial Intelligence Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.